Whale Watching in the Korea Stock Market
There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...
246 Views
Recent Developments Not Encouraging
This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...
155 Views
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
467 Views
Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...
219 Views
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
354 Views